How to buy ProPhase Labs (PRPH) shares in the UK

Learn how to easily invest in ProPhase Labs shares.

ProPhase Labs Inc (PRPH) is a publicly traded drug manufacturers-specialty and generic business based in the US. In the week up to 25 September ProPhase Labs shares plunged 11.88% to a closing position of $10.16. However, over the last 12 months, ProPhase Labs's share price has risen by 18.93% from $5.07. ProPhase Labs is listed on the NASDAQ and employs 129 staff. All prices are listed in US Dollars.

How to buy shares in ProPhase Labs

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: PRPH in this case.
  5. Research ProPhase Labs shares. The platform should provide the latest information available.
  6. Buy your ProPhase Labs shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Fees for buying 100x ProPhase Labs shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
eToro Free Stocks logo £0 $10 £2.71
£544.99 total
Capital at risk
IG Share Dealing logo £0 £250 £11.75
£554.03 total
Capital at risk
Fineco logo £0 No minimum £5.42
£547.70 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £17.37
£559.65 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £0.54
£542.82 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £16.12
£558.40 total
Capital at risk
Stake logo £0 £50 £2.71
£544.99 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £16.28
£558.56 total
Capital at risk

Full comparison of share dealing platforms

ProPhase Labs share price (NASDAQ:PRPH)

Use our graph to track the performance of PRPH stocks over time.

ProPhase Labs price performance over time

Historical closes compared with the last close of $6.03

1 week (2022-09-22) -41.23%
1 month (2022-08-29) -48.06%
3 months (2022-06-29) -49.71%
6 months (2022-03-29) -16.25%
1 year (2021-09-29) 18.93%
2 years (2020-09-29) 65.21%
3 years (2019-09-25) 201.50%
5 years (2017-09-29) 181.78%

Is it a good time to buy ProPhase Labs stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.

eToro Free Stocks

Invest in ProPhase Labs shares with 0% commission

  • Start investing from as little as $10
  • Pay no stamp duty on UK shares
  • Join 25 million users who trust their investments with eToro
Other fees apply. Capital at risk

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is ProPhase Labs under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.

P/E ratio

ProPhase Labs's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, ProPhase Labs shares trade at around 7x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.


ProPhase Labs's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $41.4 million (£0.0 million).

The EBITDA is a measure of a ProPhase Labs's overall financial performance and is widely used to measure a its profitability.

ProPhase Labs shares at a glance

Information last updated 2021-07-09.
Previous close$6.11
Change %-1.3093%
Information last updated 2022-09-25.
52-week range$4.5346 - $15.25
50-day moving average$11.3118
200-day moving average$8.9494
Wall St. target price$11.67
PE ratio6.8649
Dividend yield$0 (0%)
Earnings per share (TTM)$1.48

Do ProPhase Labs shares pay dividends?


Forward annual dividend yield: 13.16% of stock value


Dividend payout ratio: 35.93% of net profits

ProPhase Labs has paid out, on average, around 35.93% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 13.16% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 13.16% return on their shares, in the form of dividend payments. In ProPhase Labs's case, that would currently equate to about $0 per share.

While ProPhase Labs's payout ratio might seem fairly standard, it's worth remembering that it may be investing much of the rest of its net profits in future growth.

ProPhase Labs's most recent dividend payout was on 3 June 2022. The latest dividend was paid out to all shareholders who bought their shares by 24 May 2022 (the "ex-dividend date").

Share price volatility

Over the last 12 months, ProPhase Labs's shares have ranged in value from as little as $4.5346 up to $15.25. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ProPhase Labs's is -0.4195. This would suggest that ProPhase Labs's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, ProPhase Labs has bucked the trend.

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site